Michel Lagarde - May 14, 2024 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Role
Executive Vice President & COO
Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Michel Lagarde
Stock symbol
TMO
Transactions as of
May 14, 2024
Transactions value $
-$9,697,600
Form type
4
Date filed
5/15/2024, 04:16 PM
Previous filing
May 3, 2024
Next filing
Aug 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Options Exercise $2.1M +20K +110.29% $105.17 38.1K May 14, 2024 Direct
transaction TMO Common Stock Sale -$11.8M -20K -52.45% $590.05 18.1K May 14, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -20K -14.02% $0.00 123K May 14, 2024 Common Stock 20K $105.17 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $590.00 to $590.28, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The option vested in two equal installments on August 29, 2017, and 2020.